Relative risk and attributable risk needed to interpret "factors predictive of infection in cyclophosphamide-treated lupus patients": comment on the article by Pryor et al.
Alarcón
G S
GS
D003520:Cyclophosphamide / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000453:epidemiology*; D012307:Risk Factors
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide